Afecciones morfológicas e histológicas del sistema musculoesquelético por el COVID largo

Brian Johan Bustos-Viviescas, Elizabeth Lizcano Rojas, Carlos Enrique García Yerena, John Alexander García Galviz, Diego Fernando Polanco Bustos

Texto completo:

PDF

Resumen

Desde el año 2020, el planeta se encuentra inmerso en una pandemia de origen viral caracterizada por una cantidad considerable de enfermedades y muertes, esta situación también conlleva a entender que la infección aguda pueda transformarse en una fase prolongada de efectos posteriores a la COVID-19, cuya naturaleza se encuentra todavía en proceso de esclarecimiento, además de los efectos inmediatos tras la infección, tanto los pacientes como la sociedad en general se enfrentan con el obstáculo de las consecuencias en salud de larga duración relacionadas con la COVID-19, ampliamente denominadas como COVID largo o prolongado.

Palabras clave

afecciones morfológicas; afecciones histológicas del sistema musculoesquelético; COVID largo

Referencias

Salci MA, Carreira L, Facchini LA, et al. Post-acute COVID and long-COVID among adults and older adults in the State of Paraná, Brazil: protocol for an ambispective cohort study. BMJ Open. 2022;12(9):e061094. DOI: 10.1136/bmjopen-2022-061094

Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its Management. Int J Biol Sci. 2022;18(12):4768-4780. DOI: 10.7150/ijbs.75056

Soares MN, Eggelbusch M, Naddaf E, Gerrits KHL, van der Schaaf M, van den Borst B, et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J Cachexia Sarcopenia Muscle. 2022;13(1):11–22. DOI: 10.1002/jcsm.12896

Meacci E, Pierucci F, Garcia-Gil M. Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids. Biomedicines. 2022;10(5):1068. DOI: 10.3390/biomedicines10051068

Rahiminezhad E, Zakeri MA, Dehghan M. Muscle strength/intensive care unit acquired weakness in COVID-19 and non-COVID-19 patients [published online ahead of print, 2022 Jul 27]. Nurs Crit Care. 2022;10.1111/nicc.12830. DOI: 10.1111/nicc.12830

Arena R, Myers J, Ozemek C, et al. An Evolving Approach to Assessing Cardiorespiratory Fitness, Muscle Function and Bone and Joint Health in the COVID-19 Era. Curr Probl Cardiol. 2022;47(1):100879. DOI: 10.1016/j.cpcardiol.2021.100879

Suh J, Mukerji SS, Collens SI, Padera RF Jr, Pinkus GS, Amato AA, et al. Skeletal muscle and peripheral nerve histopathology in COVID-19. Neurology. 2021;97(8):e849–58. DOI: 10.1212/wnl.0000000000012344

Agergaard J, Leth S, Pedersen TH, Harbo T, Blicher JU, Karlsson P, et al. Myopathic changes in patients with long-term fatigue after COVID-19. Clin Neurophysiol. 2021;132(8):1974–81. DOI: 10.1016/j.clinph.2021.04.009

Agergaard J, Yamin Ali Khan B, Engell-Sørensen T, Schiøttz-Christensen B, Østergaard L, Hejbøl EK, et al. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology. Clin Neurophysiol. 2023;148:65–75. DOI: 10.1016/j.clinph.2023.01.010

Ranisavljev M, Todorovic N, Ostojic J, Ostojic SM. Reduced tissue creatine levels in patients with long COVID-19: A cross-sectional study. J Postgrad Med. 2023;69(3):162-163. DOI: 10.4103/jpgm.jpgm_65_23

Hejbøl EK, Harbo T, Agergaard J, Madsen LB, Pedersen TH, Østergaard LJ, et al. Myopathy as a cause of fatigue in long‐term post‐COVID ‐19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29(9):2832–41. DOI: 10.1111/ene.15435

Swarnakar R, Jenifa S, Wadhwa S. Musculoskeletal complications in long COVID-19: A systematic review. World J Virol. 2022;11(6):485-495. DOI: 10.5501/wjv.v11.i6.485

Martone AM, Tosato M, Ciciarello F, Galluzzo V, Zazzara MB, Pais C, et al. Sarcopenia as potential biological substrate of long COVID‐19 syndrome: prevalence, clinical features, and risk factors. J Cachexia Sarcopenia Muscle. 2022;13(4):1974–82. DOI: 10.1002/jcsm.12931

Finsterer J, Scorza FA. SARS-CoV-2 myopathy. J Med Virol. 2021;93(4):1852-1853. DOI: 10.1002/jmv.26550

Seeck M, Tankisi H. Clinical neurophysiological tests as objective measures for acute and long-term COVID-19. Clin Neurophysiol Pract. 2023;8:1-2. DOI: 10.1016/j.cnp.2022.10.002

Van der Feltz-Cornelis CM, Moriarty AS, Strain WD. Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder. Viruses. 2023;15(3):783. DOI: 10.3390/v15030783

Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12:698169. DOI: 10.3389/fmicb.2021.698169

Di Gennaro F, Belati A, Tulone O, et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients [published online ahead of print, 2022 Nov 30]. Intern Emerg Med. 2022;1-9. DOI: 10.1007/s11739-022-03164-w

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2024 Brian Johan Bustos-Viviescas, Elizabeth Lizcano Rojas, Carlos Enrique García Yerena, John Alexander García Galviz, Diego Fernando Polanco Bustos

Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.